Reply: Clinical studies on coronavirus disease 2019 (COVID-19) in the WHO registry network

• Authors: Henu Kumar Verma, Institute of Experimental Endocrinology and Oncology CNR; Neha Merchant, Emory University; LVKS Bhaskar, Guru Ghasidas Vishwavidyalaya
• Journal Title: Biomedical Journal
• Volume: Volume 45, Number 1
• Publisher: Wolters Kluwer Health and Medknow Publications | 2022-02-01, Pages 217-218
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1016/j.bj.2021.10.008
• Subjects: Biology, Cell; Health Sciences, Oncology
• Keywords: COVID-19

Abstract

We would like to thank the authors for their knowledgeable comments on our study and for clarifying aspects of our methodology in relation to these concerns. We would also like to thank the author and his colleagues for their interest in our recently published paper “Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19)” [1], and for taking the time to express their concerns.